BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 12145693)

  • 1. Combination of 22-oxa-1,25-dihydroxyvitamin D(3), a vitamin D(3) derivative, with vitamin K(2) (VK2) synergistically enhances cell differentiation but suppresses VK2-inducing apoptosis in HL-60 cells.
    Funato K; Miyazawa K; Yaguchi M; Gotoh A; Ohyashiki K
    Leukemia; 2002 Aug; 16(8):1519-27. PubMed ID: 12145693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined treatment of leukemia cells with vitamin K2 and 1alpha,25-dihydroxy vitamin D3 enhances monocytic differentiation along with becoming resistant to apoptosis by induction of cytoplasmic p21CIP1.
    Iguchi T; Miyazawa K; Asada M; Gotoh A; Mizutani S; Ohyashiki K
    Int J Oncol; 2005 Oct; 27(4):893-900. PubMed ID: 16142303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of a potent 20-epi-vitamin D3 analogue (KH 1060) with 9-cis-retinoic acid irreversibly inhibits clonal growth, decreases bcl-2 expression, and induces apoptosis in HL-60 leukemic cells.
    Elstner E; Linker-Israeli M; Umiel T; Le J; Grillier I; Said J; Shintaku IP; Krajewski S; Reed JC; Binderup L; Koeffler HP
    Cancer Res; 1996 Aug; 56(15):3570-6. PubMed ID: 8758928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apoptosis/differentiation-inducing effects of vitamin K2 on HL-60 cells: dichotomous nature of vitamin K2 in leukemia cells.
    Miyazawa K; Yaguchi M; Funato K; Gotoh A; Kawanishi Y; Nishizawa Y; Yuo A; Ohyashiki K
    Leukemia; 2001 Jul; 15(7):1111-7. PubMed ID: 11455981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apoptosis induction of vitamin K2 in lung carcinoma cell lines: the possibility of vitamin K2 therapy for lung cancer.
    Yoshida T; Miyazawa K; Kasuga I; Yokoyama T; Minemura K; Ustumi K; Aoshima M; Ohyashiki K
    Int J Oncol; 2003 Sep; 23(3):627-32. PubMed ID: 12888897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel vitamin D(3) analog, 21-(3-methyl-3-hydroxy-butyl)-19-nor D(3), that modulates cell growth, differentiation, apoptosis, cell cycle, and induction of PTEN in leukemic cells.
    Hisatake J; O'Kelly J; Uskokovic MR; Tomoyasu S; Koeffler HP
    Blood; 2001 Apr; 97(8):2427-33. PubMed ID: 11290607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin K2 modulates differentiation and apoptosis of both myeloid and erythroid lineages.
    Sada E; Abe Y; Ohba R; Tachikawa Y; Nagasawa E; Shiratsuchi M; Takayanagi R
    Eur J Haematol; 2010 Dec; 85(6):538-48. PubMed ID: 20887388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of vitamin K2 plus imatinib mesylate enhances induction of apoptosis in small cell lung cancer cell lines.
    Yokoyama T; Miyazawa K; Yoshida T; Ohyashiki K
    Int J Oncol; 2005 Jan; 26(1):33-40. PubMed ID: 15586222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin K2 induces autophagy and apoptosis simultaneously in leukemia cells.
    Yokoyama T; Miyazawa K; Naito M; Toyotake J; Tauchi T; Itoh M; Yuo A; Hayashi Y; Georgescu MM; Kondo Y; Kondo S; Ohyashiki K
    Autophagy; 2008 Jul; 4(5):629-40. PubMed ID: 18376138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel role of vitamin K2: a potent inducer of differentiation of various human myeloid leukemia cell lines.
    Sakai I; Hashimoto S; Yoda M; Hida T; Ohsawa S; Nakajo S; Nakaya K
    Biochem Biophys Res Commun; 1994 Dec; 205(2):1305-10. PubMed ID: 7802663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myeloid and monocytoid leukemia cells have different sensitivity to differentiation-inducing activity of deoxyadenosine analogs.
    Niitsu N; Umeda M; Honma Y
    Leuk Res; 2000 Jan; 24(1):1-9. PubMed ID: 10634639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of vitamin D derivatives and retinoids in the differentiation of human leukaemia cells.
    James SY; Williams MA; Kelsey SM; Newland AC; Colston KW
    Biochem Pharmacol; 1997 Sep; 54(5):625-34. PubMed ID: 9337080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines.
    Koike M; Koshizuka K; Kawabata H; Yang R; Taub HE; Said J; Uskokovic M; Tsuruoka N; Koeffler HP
    Anticancer Res; 1999; 19(3A):1689-97. PubMed ID: 10470102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of a functional vitamin D receptor in all-trans-retinoic acid-induced monocytic differentiation of M2-type leukemic blast cells.
    Manfredini R; Trevisan F; Grande A; Tagliafico E; Montanari M; Lemoli R; Visani G; Tura S; Ferrari S; Ferrari S
    Cancer Res; 1999 Aug; 59(15):3803-11. PubMed ID: 10446999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin K2 and cotylenin A synergistically induce monocytic differentiation and growth arrest along with the suppression of c-MYC expression and induction of cyclin G2 expression in human leukemia HL-60 cells.
    Maniwa Y; Kasukabe T; Kumakura S
    Int J Oncol; 2015 Aug; 47(2):473-80. PubMed ID: 26046133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The synergistic antitumor activity of arsenic trioxide and vitamin K2 in HL-60 cells involves increased ROS generation and regulation of the ROS-dependent MAPK signaling pathway.
    Qu H; Tong D; Zhang Y; Kang K; Zhang Y; Chen L; Ren L
    Pharmazie; 2013 Oct; 68(10):839-45. PubMed ID: 24273890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of activity of 1alpha, 25-dihydroxyvitamin D3 for growth inhibition and differentiation induction of human myelomonocytic leukemia cells by tretinoin tocoferil, an alpha-tocopherol ester of all-trans retinoic acid.
    Makishima M; Kanatani Y; Yamamoto-Yamaguchi Y; Honma Y
    Blood; 1996 Apr; 87(8):3384-94. PubMed ID: 8605356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TRAIL (Apo2L) suppresses growth of primary human leukemia and myelodysplasia progenitors.
    Plasilova M; Zivny J; Jelinek J; Neuwirtova R; Cermak J; Necas E; Andera L; Stopka T
    Leukemia; 2002 Jan; 16(1):67-73. PubMed ID: 11840265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic effects of curcumin on all-trans retinoic acid- and 1 alpha,25-dihydroxyvitamin D3-induced differentiation in human promyelocytic leukemia HL-60 cells.
    Liu Y; Chang RL; Cui XX; Newmark HL; Conney AH
    Oncol Res; 1997; 9(1):19-29. PubMed ID: 9112257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancing effects of ceramide derivatives on 1,25-dihydroxyvitamin D(3)-induced differentiation of human HL-60 leukemia cells.
    Kim DS; Kim SH; Song JH; Chang YT; Hwang SY; Kim TS
    Life Sci; 2007 Dec; 81(25-26):1638-44. PubMed ID: 18031762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.